Search Within

Andrew D Zelenetz

Formats
  1. Meeting Abstract (461)
  2. Journal Article (288)
  3. Research Letter (14)
  4. Book Section (7)
  5. Guidelines (5)
  6. Conference Paper (3)
  7. Correspondence (3)
  8. Editorial (3)
  9. Review (1)
Groups
  1. Center for Hematologic Malignancies (785)
  2. Department of Medicine (785)
  3. Hematologic Malignancies, Division of (785)
  4. Lymphoma (785)
  5. Survivorship Research (234)
  6. Population Sciences Research Program (189)

More Groups

People
  1. Craig Moskowitz (207)
  2. Ariela Noy (188)
  3. Paul Hamlin (187)
  4. Steven Horwitz (169)
  5. David Straus (163)
  6. Maria Palomba (143)

More People

Years
  1. 2025 (8)
  2. 2024 (31)
  3. 2023 (43)
  4. 2022 (30)
  5. 2021 (29)
  6. 2020 (32)

More Years

Publications
  1. Blood (329)
  2. Journal of Clinical Oncology (83)
  3. Journal of the National Comprehensive Cancer Network (35)
  4. British Journal of Haematology (34)
  5. Leukemia and Lymphoma (31)
  6. Annals of Oncology (26)

More Publications

Publishers
  1. American Society of Hematology (341)
  2. American Society of Clinical Oncology (85)
  3. John Wiley & Sons (41)
  4. Harborside Press (35)
  5. Elsevier Inc. (31)
  6. Oxford University Press (31)

More Publishers

Results (785)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials
    Meeting Abstract

    Barrientos, J. C.; Ghia, P.; Pagel, J.; Salles, G. A.; Sharman, J. P.; Stilgenbauer, S.; Gurtovaya, O.; Kim, Y.; Philip, B.; Zelenetz, A. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • In support of a patient-driven initiative and petition to lower the high price of cancer drugs
    Journal Article

    Tefferi, A.; Kantarjian, H.; Rajkumar, S. V.; Baker, L. H.; Abkowitz, J. L.; Adamson, J. W.; Advani, R. H.; Allison, J.; Antman, K. H.; Bast, R. C. Jr; more...
    Mayo Clinic Proceedings (2015)

    Fulltext@MSK | Save
  • Prospective evaluation of interim and end of treatment PET in patients with de novo DLBCL treated with GA101+CHOP in phase II GATHER study
    Meeting Abstract

    Hutchings, M.; Kostakoglu, L.; Fingerle-Rowson, G.; de Crespigny, A.; Vignal, C.; Mobasher, M.; Zelenetz, A. D.
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • Emerging treatment options for B-cell lymphomas
    Conference Paper

    Zelenetz, A. D.
    Harborside Press (2015)

    Fulltext@MSK | Save
  • NCCN roundtable: What are the characteristics of an optimal clinical practice guideline?
    Conference Paper

    Ettinger, D. S.; Kuettel, M.; Malin, J.; McClure, J. S.; Smith, M. L.; Zelenetz, A. D.; Stewart, F. M.
    Harborside Press (2015)

    Fulltext@MSK | Save
  • Treatment response of cutaneous mantle cell lymphoma to ibrutinib and radiotherapy
    Journal Article

    Mancebo, S. E.; Smith, J. R.; Intlekofer, A. M.; Zelenetz, A. D.; Myskowski, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
    Journal Article

    Nabhan, C.; Byrtek, M.; Rai, A.; Dawson, K.; Zhou, X.; Link, B. K.; Friedberg, J. W.; Zelenetz, A. D.; Maurer, M. J.; Cerhan, J. R.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Update on a phase 2 study of idelalisib in combination with rituximab in treatment-naive patients >= 65 years with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    Dubowy, R.; O'Brien, S.; Lamanna, N.; Kipps, T.; Flinn, I.; Zelenetz, A.; Burger, J.; Holes, L.; Cho, Y.; Coutre, S.
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Health-related quality of life impact of idelalisib in patients with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results
    Meeting Abstract

    Munir, T.; Hillmen, P.; Eradat, H.; Ghia, P.; O'Brien, S.; Furman, R.; Coutre, S.; Sharman, J.; Cheson, B.; Pagel, J.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Second interim analysis of a phase 3 study of idelalisib plus rituximab (R) for relapsed chronic lymphocytic leukaemia (CLL): Efficacy analysis in patient subpopulations with Del(17p) and other adverse prognostic factors
    Meeting Abstract

    Munir, T.; Hillmen, P.; Sharman, J.; Coutre, S.; Furman, R.; Cheson, B.; Pagel, J.; Barrientos, J.; Zelenetz, A.; Kipps, T.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save